163 results on '"van Andel G"'
Search Results
2. Urinary incontinence and erectile dysfunction in patients with localized or locally advanced prostate cancer: A nationwide observational study
Catalog
Books, media, physical & digital resources
3. The membranous urethral length: A continence predictor on MRI with high interobserver variability
4. Corrigendum to 'Urinary incontinence and erectile dysfunction in patients with localized or locally advanced prostate cancer: A nationwide observational study' (Urologic Oncology: Seminars and Original Investigations (2020) 38(9) (735.e17–735.e25), (S1078143920302519), (10.1016/j.urolonc.2020.05.022))
5. Evaluating machine learning algorithms to Predict 30-day Unplanned REadmission (PURE) in Urology patients.
6. Real-world outcomes of first-line chemotherapy for unresectable stage III and IV bladder cancer.
7. Complications of transperineal prostate biopsies with antibiotic prophylaxis on indication only versus transrectal prostate biopsies with standard prophylactic antibiotics
8. Sulpicius Severus and Origenism
9. A randomized study comparing epirubicin in a 4-weekly versus a weekly intravenous regimen in patients with metastatic, hormone resistant, prostatic carcinoma: effects on health related quality of life
10. Quality-of-life assessment in bladder cancer
11. The effect on quality of life of androgen deprivation therapy (ADT) combined with local external prostate radiotherapy in patients with primary metastatic prostate cancer, results from the HORRAD trial
12. Quality of life in patients with prostatic carcinoma: A review and results of a study in N+ disease Prostate-specific antigen as predictor of quality of life
13. EO4 - The membranous urethral length: A continence predictor on MRI with high interobserver variability
14. Health-related quality of life and psychosocial factors in patients with prostate cancer scheduled for radical prostatectomy or external radiation therapy
15. The Impact of Androgen Deprivation Therapy on Health Related Quality of Life in Asymptomatic Men with Lymph Node Positive Prostate Cancer
16. Lokale behandeling bij het primair gemetastaseerd prostaatcarcinoom = Local therapy in primary metastatic prostate cancer
17. A0115 - Complications of transperineal prostate biopsies with antibiotic prophylaxis on indication only versus transrectal prostate biopsies with standard prophylactic antibiotics
18. PROSTATIC CARCINOMA TREATED BY BRACHY-THERAPY WITH I-125 : IS CURE POSSIBLE?
19. Het effect op de kwaliteit van leven van hormonale behandeling versus gecombineerde hormonale en lokale externe radiotherapeutische behandeling bij patiënten met een primair ossaal gemetastaseerd prostaatcarcinoom
20. Het perioperatieve antistollingsbeleid in de urologische praktijk in Nederland
21. Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis
22. Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis
23. Evaluation of the diagnostic workup in young women referred for recurrent lower urinary tract infections
24. Value of diagnostic ultrasound in patients with chronic scrotal pain and normal findings on clinical examination
25. Review of the Results of the Dotter Procedure
26. Transluminal Dilatation With Separate Teflon Catheters
27. The influence of psychosocial factors on the measured quality of life (QoL) in patients suffering from benign prostate hyperplasia (BPH) and patients with prostate cancer (PC)
28. Education and counseling in cancer: the neglected case of the prostate cancer patients
29. Duration of androgen suppression in the treatment of prostate cancer
30. Psychosomatic Investigations on Patients with Heart Complaints, Respectively on a Physical and Non-Physical Basis
31. 997 EORTC nomograms for predicting recurrence, progression, overall and disease specific survival in non-muscle invasive Ta T1 bladder cancer patients treated with maintenance Bacillus Calmette-Guerin
32. Aspects of health related quality of life in prostate cancer
33. Meer inzicht in praktijkvoering: Diagnose-behandel-combinaties ondersteunen medisch specialisten
34. A randomised study about the effect on survival of hormonal therapy versus hormonal therapy plus local external radiation therapy in patients with primary diagnosed metastasised (M+) prostate cancer
35. 1050 Bacillus Calmette-Guerin: One third dose versus full dose and one year versus three years of maintenance. Final results of an EORTC GU Cancers Group randomized trial in non muscle invasive bladder cancer
36. Is baseline quality of life useful for predicting survival with hormone-refractory prostate cancer? A pooled analysis of three studies of the European Organisation for Research and Treatment of Cancer Genitourinary Group
37. 659 EFFECT OF AGE ON TREATMENT OUTCOME AND TOLERANCE IN PATIENTS WITH STAGE TA T1 PAPILLARY CARCINOMA OF THE BLADDER TREATED WITH MAINTENANCE BACILLUS CALMETTEGUERIN: RESULTS OF EORTC GU GROUP STUDY 30911
38. URINE CYTOLOGY IS OF NO ADDED VALUE IN THE PRIMARY EVALUATION OF PATIENTS WITH HEMATURIA
39. A Prospective longitudinal study comparing the impact of external radiation therapy with radical prostatectomy on health related quality of life (HRQOL) in prostate cancer patients
40. 910 The level of reporting of health-related quality of life in cancer research. Evidence from 123 randomised controlled trials enrolling 36220 cancer patients
41. Baseline quality of life measured with the EORTC QLQ-C30 helps to select a subset of ‘good prognosis’ metastatic hormone refractory prostate cancer patients
42. Quality of Life Assessment in Patients with Hormone–Resistant Prostate Cancer Treated with Epirubicin or with Epirubicin plus Medroxy Progesterone Acetate – Is It Feasible?
43. Psychosocial factors and the course of prostate cancer
44. 158 O - PSA doubling time after brachytherapy with I-125 for prostatic carcinoma category T1c-3G1-3N0M0
45. 160 O - Quality of life assessment in patients with prostatic carcinoma category T1-3 N1-3 MO, receiving or not receiving hormonal treatment
46. Health-related quality of life in Dutch men with prostate cancer.
47. Changes in health-related quality of life of men with prostate cancer 3 months after diagnosis: the role of psychosocial factors and comparisment with benign prostate hyperplasia patients.
48. Psychosocial and educational aspects in prostate cancer patients.
49. Quality of Life Assessment in Patients with Hormone–Resistant Prostate Cancer Treated with Epirubicin or with Epirubicin plus Medroxy Progesterone Acetate – Is It Feasible?
50. Arterial occlusion following angiography
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.